Cargando…
Ligand modulation of sidechain dynamics in a wild-type human GPCR
GPCRs regulate all aspects of human physiology, and biophysical studies have deepened our understanding of GPCR conformational regulation by different ligands. Yet there is no experimental evidence for how sidechain dynamics control allosteric transitions between GPCR conformations. To address this...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650471/ https://www.ncbi.nlm.nih.gov/pubmed/28984574 http://dx.doi.org/10.7554/eLife.28505 |
_version_ | 1783272719821832192 |
---|---|
author | Clark, Lindsay D Dikiy, Igor Chapman, Karen Rödström, Karin EJ Aramini, James LeVine, Michael V Khelashvili, George Rasmussen, Søren GF Gardner, Kevin H Rosenbaum, Daniel M |
author_facet | Clark, Lindsay D Dikiy, Igor Chapman, Karen Rödström, Karin EJ Aramini, James LeVine, Michael V Khelashvili, George Rasmussen, Søren GF Gardner, Kevin H Rosenbaum, Daniel M |
author_sort | Clark, Lindsay D |
collection | PubMed |
description | GPCRs regulate all aspects of human physiology, and biophysical studies have deepened our understanding of GPCR conformational regulation by different ligands. Yet there is no experimental evidence for how sidechain dynamics control allosteric transitions between GPCR conformations. To address this deficit, we generated samples of a wild-type GPCR (A(2A)R) that are deuterated apart from (1)H/(13)C NMR probes at isoleucine δ1 methyl groups, which facilitated (1)H/(13)C methyl TROSY NMR measurements with opposing ligands. Our data indicate that low [Na(+)] is required to allow large agonist-induced structural changes in A(2A)R, and that patterns of sidechain dynamics substantially differ between agonist (NECA) and inverse agonist (ZM241385) bound receptors, with the inverse agonist suppressing fast ps-ns timescale motions at the G protein binding site. Our approach to GPCR NMR creates a framework for exploring how different regions of a receptor respond to different ligands or signaling proteins through modulation of fast ps-ns sidechain dynamics. |
format | Online Article Text |
id | pubmed-5650471 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-56504712017-10-23 Ligand modulation of sidechain dynamics in a wild-type human GPCR Clark, Lindsay D Dikiy, Igor Chapman, Karen Rödström, Karin EJ Aramini, James LeVine, Michael V Khelashvili, George Rasmussen, Søren GF Gardner, Kevin H Rosenbaum, Daniel M eLife Biochemistry and Chemical Biology GPCRs regulate all aspects of human physiology, and biophysical studies have deepened our understanding of GPCR conformational regulation by different ligands. Yet there is no experimental evidence for how sidechain dynamics control allosteric transitions between GPCR conformations. To address this deficit, we generated samples of a wild-type GPCR (A(2A)R) that are deuterated apart from (1)H/(13)C NMR probes at isoleucine δ1 methyl groups, which facilitated (1)H/(13)C methyl TROSY NMR measurements with opposing ligands. Our data indicate that low [Na(+)] is required to allow large agonist-induced structural changes in A(2A)R, and that patterns of sidechain dynamics substantially differ between agonist (NECA) and inverse agonist (ZM241385) bound receptors, with the inverse agonist suppressing fast ps-ns timescale motions at the G protein binding site. Our approach to GPCR NMR creates a framework for exploring how different regions of a receptor respond to different ligands or signaling proteins through modulation of fast ps-ns sidechain dynamics. eLife Sciences Publications, Ltd 2017-10-06 /pmc/articles/PMC5650471/ /pubmed/28984574 http://dx.doi.org/10.7554/eLife.28505 Text en © 2017, Clark et al http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Biochemistry and Chemical Biology Clark, Lindsay D Dikiy, Igor Chapman, Karen Rödström, Karin EJ Aramini, James LeVine, Michael V Khelashvili, George Rasmussen, Søren GF Gardner, Kevin H Rosenbaum, Daniel M Ligand modulation of sidechain dynamics in a wild-type human GPCR |
title | Ligand modulation of sidechain dynamics in a wild-type human GPCR |
title_full | Ligand modulation of sidechain dynamics in a wild-type human GPCR |
title_fullStr | Ligand modulation of sidechain dynamics in a wild-type human GPCR |
title_full_unstemmed | Ligand modulation of sidechain dynamics in a wild-type human GPCR |
title_short | Ligand modulation of sidechain dynamics in a wild-type human GPCR |
title_sort | ligand modulation of sidechain dynamics in a wild-type human gpcr |
topic | Biochemistry and Chemical Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650471/ https://www.ncbi.nlm.nih.gov/pubmed/28984574 http://dx.doi.org/10.7554/eLife.28505 |
work_keys_str_mv | AT clarklindsayd ligandmodulationofsidechaindynamicsinawildtypehumangpcr AT dikiyigor ligandmodulationofsidechaindynamicsinawildtypehumangpcr AT chapmankaren ligandmodulationofsidechaindynamicsinawildtypehumangpcr AT rodstromkarinej ligandmodulationofsidechaindynamicsinawildtypehumangpcr AT araminijames ligandmodulationofsidechaindynamicsinawildtypehumangpcr AT levinemichaelv ligandmodulationofsidechaindynamicsinawildtypehumangpcr AT khelashviligeorge ligandmodulationofsidechaindynamicsinawildtypehumangpcr AT rasmussensørengf ligandmodulationofsidechaindynamicsinawildtypehumangpcr AT gardnerkevinh ligandmodulationofsidechaindynamicsinawildtypehumangpcr AT rosenbaumdanielm ligandmodulationofsidechaindynamicsinawildtypehumangpcr |